molecules of the month


oral serine _-lactamase inh. prodrug

restores ceftibuten activity in model, Ph. I

hydrolysis transition state mimetic

Journal of Medicinal Chemistry

Venatorx Pharmaceuticals, Malvern, US

1 min read

11. The Venatorx serine _-lactamase inhibitor VNRX-7145 is an orally bioavailable prodrug of the boronic acid-containing inhibitor VNRX-5236, and is currently in Ph. I. It demonstrates activity in vitro and in vivo covering Enterobacterales expressing key class A or D carbapenemases or class C cephalosporinases. In preclinical studies, the inhibitor VNRX-7145 restored ceftibuten activity in a mouse model of UTI due to ESBL- and KPC-carbapenemase-producing strains of E. coli and K. pneumoniae. A related molecule, QPX7728, was covered in Apr. 2020.

request a trial

You don’t have time to read everything, but you can’t afford to fall behind.

Drug Hunter Premium is drug discovery, distilled, so you can quickly catch up and make informed decisions based on industry examples.

Get ahead now by requesting a trial.

already a member? log in: